Suppr超能文献

炎症小体:先天免疫系统的威胁评估细胞器。

Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.

机构信息

Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.

Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Immunity. 2019 Oct 15;51(4):609-624. doi: 10.1016/j.immuni.2019.08.005. Epub 2019 Aug 28.

Abstract

Inflammasomes are supramolecular organizing centers that operate to drive interleukin-1 (IL-1)-dependent inflammation. Depending on context, inflammatory caspases act upstream or downstream of inflammasome assembly, serving as the principal enzymes that control activities of these organelles. In this review, we discuss mechanisms of inflammasome assembly and signaling. We posit that upstream regulatory proteins, classically known as pattern-recognition receptors, operate to assess infectious and non-infectious threats to the host. Threat assessment is achieved through two general strategies: (1) direct binding of receptors to microbial or host-derived ligands or (2) indirect detection of changes in cellular homeostasis. Upon activation, these upstream regulatory factors seed the assembly of inflammasomes, leading to IL-1 family cytokine release from living (hyperactive) or dead (pyroptotic) cells. The molecular and physiological consequences of these distinct cell fate decisions are discussed.

摘要

炎症小体是一种超分子组装中心,可驱动白细胞介素-1(IL-1)依赖性炎症。根据具体情况,炎性半胱天冬酶在上游或炎症小体组装的下游起作用,作为控制这些细胞器活性的主要酶。在这篇综述中,我们讨论了炎症小体的组装和信号转导机制。我们假设上游调节蛋白,通常称为模式识别受体,用于评估宿主受到的感染和非感染威胁。威胁评估是通过两种一般策略实现的:(1)受体与微生物或宿主来源的配体直接结合,或(2)间接检测细胞内稳态的变化。在激活后,这些上游调节因子引发炎症小体的组装,导致活(过度活跃)或死(细胞焦亡)细胞释放白细胞介素-1 家族细胞因子。讨论了这些不同细胞命运决定的分子和生理后果。

相似文献

1
Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.炎症小体:先天免疫系统的威胁评估细胞器。
Immunity. 2019 Oct 15;51(4):609-624. doi: 10.1016/j.immuni.2019.08.005. Epub 2019 Aug 28.
3
Inflammasomes and their roles in health and disease.炎症小体及其在健康和疾病中的作用。
Annu Rev Cell Dev Biol. 2012;28:137-61. doi: 10.1146/annurev-cellbio-101011-155745. Epub 2012 Sep 10.
6
Regulation of inflammasome activation.炎性小体激活的调控
Immunol Rev. 2015 May;265(1):6-21. doi: 10.1111/imr.12296.
7
The nucleic acid-sensing inflammasomes.核酸感应炎性小体。
Immunol Rev. 2015 May;265(1):103-11. doi: 10.1111/imr.12281.
9
Regulation of inflammasome signaling.炎症小体信号的调控。
Nat Immunol. 2012 Mar 19;13(4):333-42. doi: 10.1038/ni.2237.

引用本文的文献

4
Progress in cytokine research for ARDS: A comprehensive review.急性呼吸窘迫综合征细胞因子研究进展:综述
Open Med (Wars). 2024 Oct 28;19(1):20241076. doi: 10.1515/med-2024-1076. eCollection 2024.
7
Activation of the NLRP1B inflammasome by caspase-8.NLRP1B 炎性小体被半胱天冬酶-8 激活。
Commun Biol. 2024 Sep 17;7(1):1164. doi: 10.1038/s42003-024-06882-3.
8
Novel cortisol trajectory sub-phenotypes in sepsis.脓毒症中新型皮质醇轨迹亚表型。
Crit Care. 2024 Sep 3;28(1):290. doi: 10.1186/s13054-024-05071-2.
9
Cyclic GMP-AMP synthase recognizes the physical features of DNA.环状GMP-AMP合酶识别DNA的物理特征。
Acta Pharmacol Sin. 2025 Feb;46(2):264-270. doi: 10.1038/s41401-024-01369-7. Epub 2024 Aug 7.

本文引用的文献

1
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.NEK7 许可激活 NLRP3 炎症小体的结构机制。
Nature. 2019 Jun;570(7761):338-343. doi: 10.1038/s41586-019-1295-z. Epub 2019 Jun 12.
6
N-terminal degradation activates the NLRP1B inflammasome.N 端降解激活 NLRP1B 炎性小体。
Science. 2019 Apr 5;364(6435):82-85. doi: 10.1126/science.aau1208. Epub 2019 Mar 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验